we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.
Key Points: COVID In today’s Recommendation for Industry, we discuss the alternating status of monkeypox and Covid. Read more below. FDA authorizes updated COVID
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19
Intended to help consumers easily identify any bioengineered (BE) ingredients in foods, the USDA BE foods labeling standard, which became mandatory this year, is
A recent study commissioned by the Food Standards Agency (FSA) of the UK found that not only do many aspects of Canada’s food safety
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied
Over the last year, thousands of products have been recalled in Europe due to the presence of ethylene oxide (EtO) or its breakdown products,
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after
If the research and development efforts of the National Institute of Standards and Technology (NIST) pan out, the U.S. could soon have a roadside
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health
© 2026 The Acheson Group. All rights reserved